N-terminal tagging of the dopamine transporter impairs protein expression and trafficking in vivo

Molecular and Cellular Neuroscience

Volumn 61, Issue , 2014, Pages 123-132

  Vecchio, Laura M ^a   Bermejo, M Kristel ^a   Beerepoot, Pieter ^a   Ramsey, Amy J ^a   Salahpour, Ali ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE TRANSPORTER; MESSENGER RNA; PROTEIN; AMPHETAMINE; DOPAMINE; PEPTIDE FRAGMENT;

AMINO TERMINAL SEQUENCE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; GENOME; HYPERACTIVITY; IN VIVO STUDY; KNOCKOUT MOUSE; LOCOMOTION; MESENCEPHALON; MOUSE; NERVE ENDING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; PROTEIN STABILITY; TRANSGENIC MOUSE; ANIMAL; C57BL MOUSE; CHEMISTRY; COPY NUMBER VARIATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT; SYNAPTOSOME; ULTRASTRUCTURE;

AMPHETAMINE; ANIMALS; CORPUS STRIATUM; DNA COPY NUMBER VARIATIONS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; GENE EXPRESSION REGULATION; LOCOMOTION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; PROTEIN TRANSPORT; RNA, MESSENGER; SYNAPTOSOMES;

EID: 84903785168     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2014.05.007     Document Type: Article

References (59)

1. Ballester M., Castello A., Ibanez E., Sanchez A., Folch J.M. Real-time quantitative PCR-based system for determining transgene copy number in transgenic animals. Biotechniques 2004, 37:610-613.
2. Bjerggaard C., Fog J.U., Hastrup H., Madsen K., Loland C.J., Javitch J.A., Gether U. Surface targeting of the dopamine transporter involves discrete epitopes in the distal C terminus but does not require canonical PDZ domain interactions. J. Neurosci. 2004, 24:7024-7036.
3. Burkhart C.A., Norris M.D., Haber M. A simple method for the isolation of genomic DNA from mouse tail free of real-time PCR inhibitors. J. Biochem. Biophys. Methods 2002, 52:145-149.
4. Cagniard B., Sotnikova T.D., Gainetdinov R.R., Zhuang X. The dopamine transporter expression level differentially affects responses to cocaine and amphetamine. Journal of neurogenetics 2014, 28:112-121.
5. Carneiro A.M., Ingram S.L., Beaulieu J.M., Sweeney A., Amara S.G., Thomas S.M., Caron M.G., Torres G.E. The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter. J. Neurosci. 2002, 22:7045-7054.
6. Carvelli L., McDonald P.W., Blakely R.D., Defelice L.J. Dopamine transporters depolarize neurons by a channel mechanism. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:16046-16051.
7. Carvelli L., Blakely R.D., DeFelice L.J. Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:14192-14197.
8. Caudle W.M., Richardson J.R., Wang M.Z., Taylor T.N., Guillot T.S., McCormack A.L., Colebrooke R.E., Di Monte D.A., Emson P.C., Miller G.W. Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration. J. Neurosci. 2007, 27:8138-8148.
9. Cervinski M.A., Foster J.D., Vaughan R.A. Syntaxin 1A regulates dopamine transporter activity, phosphorylation and surface expression. Neuroscience 2010, 170:408-416.
10. D'Haene B., Vandesompele J., Hellemans J. Accurate and objective copy number profiling using real-time quantitative PCR. Methods 2010, 50:262-270.
11. Foster J.D., Pananusorn B., Vaughan R.A. Dopamine transporters are phosphorylated on N-terminal serines in rat striatum. J. Biol. Chem. 2002, 277:25178-25186.
12. Foster J.D., Cervinski M.A., Gorentla B.K., Vaughan R.A. Regulation of the dopamine transporter by phosphorylation. Handb. Exp. Pharmacol. 2006, 197-214.
13. Fukushima S., Shen H., Hata H., Ohara A., Ohmi K., Ikeda K., Numachi Y., Kobayashi H., Hall F.S., Uhl G.R., Sora I. Methamphetamine-induced locomotor activity and sensitization in dopamine transporter and vesicular monoamine transporter 2 double mutant mice. Psychopharmacology (Berl.) 2007, 193:55-62.
14. Gainetdinov R.R., Caron M.G. Monoamine transporters: from genes to behavior. Annu. Rev. Pharmacol. Toxicol. 2003, 43:261-284.
15. Gainetdinov R.R., Jones S.R., Fumagalli F., Wightman R.M., Caron M.G. Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis. Brain Res. Brain Res. Rev. 1998, 26:148-153.
16. Gainetdinov R.R., Jones S.R., Caron M.G. Functional hyperdopaminergia in dopamine transporter knock-out mice. Biol. Psychiatry 1999, 46:303-311.
17. Gainetdinov R.R., Wetsel W.C., Jones S.R., Levin E.D., Jaber M., Caron M.G. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 1999, 283:397-401.
18. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996, 379:606-612.
19. Gong S., Yang X.W. Modification of bacterial artificial chromosomes (BACs) and preparation of intact BAC DNA for generation of transgenic mice. Curr. Protoc. Neurosci. 2005, 31:5.21.1-5.21.13.
20. Gong S., Yang X.W., Li C., Heintz N. Highly efficient modification of bacterial artificial chromosomes (BACs) using novel shuttle vectors containing the R6Kgamma origin of replication. Genome Res. 2002, 12:1992-1998.
21. Hastrup H., Karlin A., Javitch J.A. Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:10055-10060.
22. Hastrup H., Sen N., Javitch J.A. The human dopamine transporter forms a tetramer in the plasma membrane: cross-linking of a cysteine in the fourth transmembrane segment is sensitive to cocaine analogs. J. Biol. Chem. 2003, 278:45045-45048.
23. Hu Y.F., Caron M.G., Sieber-Blum M. Norepinephrine transport-mediated gene expression in noradrenergic neurogenesis. BMC Genomics 2009, 10:151.
24. Javitch J.A., D'Amato R.J., Strittmatter S.M., Snyder S.H. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. U. S. A. 1985, 82:2173-2177.
25. Iversen L.L. Role of transmitter uptake mechanisms in synaptic neurotransmission. Br. J. Pharmacol. 1971, 41:571-591.
26. Khoshbouei H., Sen N., Guptaroy B., Johnson L., Lund D., Gnegy M.E., Galli A., Javitch J.A. N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. PLoS Biol. 2004, 2:E78.
27. Lee S.H., Kang S.S., Son H., Lee Y.S. The region of dopamine transporter encompassing the 3rd transmembrane domain is crucial for function. Biochem. Biophys. Res. Commun. 1998, 246:347-352.
28. Lee F.J., Liu F., Pristupa Z.B., Niznik H.B. Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis. FASEB J. 2001, 15:916-926.
29. Lee K.H., Kim M.Y., Kim D.H., Lee Y.S. Syntaxin 1A and receptor for activated C kinase interact with the N-terminal region of human dopamine transporter. Neurochem. Res. 2004, 29:1405-1409.
30. Lee F.J., Pei L., Moszczynska A., Vukusic B., Fletcher P.J., Liu F. Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor. EMBO J. 2007, 26:2127-2136.
31. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25:402-408.
32. Melikian H.E. Neurotransmitter transporter trafficking: endocytosis, recycling, and regulation. Pharmacol. Ther. 2004, 104:17-27.
33. Melikian H.E., Buckley K.M. Membrane trafficking regulates the activity of the human dopamine transporter. J. Neurosci. 1999, 19:7699-7710.
34. Miranda M., Sorkina T., Grammatopoulos T.N., Zawada W.M., Sorkin A. Multiple molecular determinants in the carboxyl terminus regulate dopamine transporter export from endoplasmic reticulum. J. Biol. Chem. 2004, 279:30760-30770.
35. Miranda M., Dionne K.R., Sorkina T., Sorkin A. Three ubiquitin conjugation sites in the amino terminus of the dopamine transporter mediate protein kinase C-dependent endocytosis of the transporter. Mol. Biol. Cell 2007, 18:313-323.
36. Moron J.A., Zakharova I., Ferrer J.V., Merrill G.A., Hope B., Lafer E.M., Lin Z.C., Wang J.B., Javitch J.A., Galli A., Shippenberg T.S. Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J. Neurosci. 2003, 23:8480-8488.
37. Mortensen O.V., Amara S.G. Dynamic regulation of the dopamine transporter. Eur. J. Pharmacol. 2003, 479:159-170.
38. Moszczynska A., Saleh J., Zhang H., Vukusic B., Lee F.J., Liu F. Parkin disrupts the alpha-synuclein/dopamine transporter interaction: consequences toward dopamine-induced toxicity. J. Mol. Neurosci. 2007, 32:217-227.
39. Nelson N. The family of Na+/Cl-neurotransmitter transporters. J. Neurochem. 1998, 71:1785-1803.
40. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
41. Rao A., Richards T.L., Simmons D., Zahniser N.R., Sorkin A. Epitope-tagged dopamine transporter knock-in mice reveal rapid endocytic trafficking and filopodia targeting of the transporter in dopaminergic axons. FASEB J. 2012, 26:1921-1933.
42. Rao A., Sorkin A., Zahniser N.R. Mice expressing markedly reduced striatal dopamine transporters exhibit increased locomotor activity, dopamine uptake turnover rate and cocaine responsiveness. Synapse 2013, 67:668-677.
43. Rickhag M., Hansen F.H., Sorensen G., Strandfelt K.N., Andresen B., Gotfryd K., Madsen K.L., Vestergaard-Klewe I., Ammendrup-Johnsen I., Eriksen J., Newman A.H., Fuchtbauer E.M., Gomeza J., Woldbye D.P., Wortwein G., Gether U. A C-terminal PDZ domain-binding sequence is required for striatal distribution of the dopamine transporter. Nat. Commun. 2013, 4:1580.
44. Salahpour A., Medvedev I.O., Beaulieu J.M., Gainetdinov R.R., Caron M.G. Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals. Biol. Psychiatry 2007, 61:65-69.
45. Salahpour A., Ramsey A.J., Medvedev I.O., Kile B., Sotnikova T.D., Holmstrand E., Ghisi V., Nicholls P.J., Wong L., Murphy K., Sesack S.R., Wightman R.M., Gainetdinov R.R., Caron M.G. Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:4405-4410.
46. Salamone J.D., Correa M. The mysterious motivational functions of mesolimbic dopamine. Neuron 2012, 76:470-485.
47. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008, 3:1101-1108.
48. Schultz W. Multiple dopamine functions at different time courses. Annu. Rev. Neurosci. 2007, 30:259-288.
49. Shepherd C.T., Moran Lauter A.N., Scott M.P. Determination of transgene copy number by real-time quantitative PCR. Methods Mol. Biol. 2009, 526:129-134.
50. Sorkina T., Miranda M., Dionne K.R., Hoover B.R., Zahniser N.R., Sorkin A. RNA interference screen reveals an essential role of Nedd4-2 in dopamine transporter ubiquitination and endocytosis. J. Neurosci. 2006, 26:8195-8205.
51. Sorkina T., Richards T.L., Rao A., Zahniser N.R., Sorkin A. Negative regulation of dopamine transporter endocytosis by membrane-proximal N-terminal residues. J. Neurosci. 2009, 29:1361-1374.
52. Torres G.E. The dopamine transporter proteome. J. Neurochem. 2006, 97(Suppl. 1):3-10.
53. Torres G.E., Yao W.D., Mohn A.R., Quan H., Kim K.M., Levey A.I., Staudinger J., Caron M.G. Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron 2001, 30:121-134.
54. Torres G.E., Carneiro A., Seamans K., Fiorentini C., Sweeney A., Yao W.D., Caron M.G. Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J. Biol. Chem. 2003, 278:2731-2739.
55. Torres G.E., Gainetdinov R.R., Caron M.G. Plasma membrane monoamine transporters: structure, regulation and function. Nat. Rev. Neurosci. 2003, 4:13-25.
56. Tye K.M., Mirzabekov J.J., Warden M.R., Ferenczi E.A., Tsai H.C., Finkelstein J., Kim S.Y., Adhikari A., Thompson K.R., Andalman A.S., Gunaydin L.A., Witten I.B., Deisseroth K. Dopamine neurons modulate neural encoding and expression of depression-related behaviour. Nature 2013, 493:537-541.
57. Vaughan R.A. Phosphorylation and regulation of psychostimulant-sensitive neurotransmitter transporters. J. Pharmacol. Exp. Ther. 2004, 310:1-7.
58. Vaughan R.A., Huff R.A., Uhl G.R., Kuhar M.J. Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes. J. Biol. Chem. 1997, 272:15541-15546.
59. Zhuang X., Oosting R.S., Jones S.R., Gainetdinov R.R., Miller G.W., Caron M.G., Hen R. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:1982-1987.